Clinical Trial Update: Sumatriptan and Naratriptan Pregnancy Registry

View source ↗

Summary

A pregnancy registry update assessing the safety of sumatriptan and naratriptan in pregnancy for migraine disorders; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Naratriptan (Naratriptan)
• Sumatriptan (Sumatriptan)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Migraine Disorders | Status: COMPLETED